* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Control of Gene Expression
Survey
Document related concepts
Transcript
How do Cells Become Specialized? • Cell Differentiation: a process where a generalized cell changes in form and function to a specialized cell (ex. neurons, RBCs) – Often triggered chemically by neighbor cells (induction) • Cell Fate: specialized function that cell acquires • Cell Potency: range of cell types that cell could acquire if exposed to different inductive environments; potency always includes fate – Totipotent cells: unlimited potency – Pluripotent cells: high, but not unlimited potency • Cell Determination: when potency becomes restricted to fate; timing can vary • Heterotopic transplantation: method for testing potency and timing of cell determination Fig. 18.14 (a) Fertilized eggs of a frog (b) Newly hatched tadpole Fig. 18.15 Unfertilized egg cell Sperm Fertilization Nucleus Two different cytoplasmic determinants Zygote Mitotic cell division Two-celled embryo (a) Cytoplasmic determinants in the egg Early embryo (32 cells) Signal transduction pathway Signal receptor Signal molecule (inducer) (b) Induction by nearby cells NUCLEUS What are In Vitro Fertilization and Embryo Screening? • In Vitro Fertilization (IVF) – Sperm and egg united in a petri dish, followed by implantation of embryo(s) into mother’s uterus; pioneered by Robert Edwards as a treatment for infertility (Nobel Prize, 2010); roughly 20-30% success rate with a single embryo – First “test-tube baby” (Louise Brown) born 25 July, 1978; more than 4 million babies born via IVF; controversies include multiple births (ex. octuplets) and un-used embryos • Embryo Screening – Cells from embryo harvested in lab (vs. amniocentesis with a fetus), and subjected to karyotyping and DNA fingerprinting – Pre-implantation genetic diagnosis (PGD): testing for genetic conditions before an embryo is chosen to be used; allows bone-marrow match for other sibling (e.g. My Sister’s Keeper) Figure 14.18 How are Clones Produced? • Cloning Techniques – Enucleated egg cell implanted with donor nucleus (frogs and mice) or fused with 8-cell blastocyst (lamb, cow, pig, and monkey) • Success rate is typically low, but improving (ex. Gaur, early 2001: 44 embryos in 32 surrogate cows led to eight pregnancies, only one successful) • Questions over health of clones: lung problems; early aging suspected • Success rate using adult donor cells varies by cell type (“Dolly” was from mammary gland cells) • Success rate increased by incubation of donor nucleii in oocyte cytoplasm Figure 20.18 What Are the Potential Applications of Cloning? • Therapeutic Cloning – Affected individual (ex. paralysis) cloned, resulting embryo used as a source of embryonic stem cells (overcomes rejection problem common with organ donations) • Cloning Organisms (Reproductive Cloning) – Conservation of endangered species (to increase population from critically low population) • Resurrection of extinct species (?) – Cloning deceased pets – Increased efficiency of biotechnology • Transgenic animals can be cloned • Production of genetically engineered organs that reduce rejections – Human reproduction when other techniques have failed (child would be genetically related to only one parent) What are Stem Cells? • Embryonic and Adult Stem Cells – Embryonic: totipotent, can be cultured stem line; can be obtained from fertility clinics (un-used embryos), or from umbilical tissue (companies store cord blood) – Adult: success varies by cell type; typically not totipotent, and potency may not last; not easily cultured, but techniques improving (cells re-programmed to embryonic state) • Potential Uses of Stem Cells – Possible treatments of diseases involving dead or damaged cells (spinal damage, Alzheimer’s, and Parkinson’s); success in several cases with mice; concerns regarding possibility of implanted cells becoming cancerous – From 2000-2008 in U.S., publicly funded research allowed only on existing stem-cell lines (some leading specialists relocated to places like Singapore); recent changes under Obama Administration challenged in the courts Figure 20.20